In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype (Q44719683)

5 December 2017

title

In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype (English)

1 reference

5 December 2017

1 reference

lymphoblastic leukemia

1 reference

1 reference

Ramakers-van Woerden NL

1 reference

5 December 2017

Beverloo HB

1 reference

5 December 2017

Veerman AJ

1 reference

5 December 2017

Camitta BM

1 reference

5 December 2017

Loonen AH

1 reference

5 December 2017

van Wering ER

1 reference

5 December 2017

Slater RM

1 reference

5 December 2017

Harbott J

1 reference

5 December 2017

den Boer ML

1 reference

5 December 2017

Ludwig WD

1 reference

5 December 2017

Haas OA

1 reference

5 December 2017

Janka-Schaub GE

1 reference

5 December 2017

Pieters R

1 reference

5 December 2017

publication date

1 March 2004

1 reference

5 December 2017

1 reference

5 December 2017

1 reference

5 December 2017

1 reference

5 December 2017

page(s)

521-529

1 reference

Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403253

The drug resistance-related protein LRP is the human major vault protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403253

Mechanisms of cellular anthracycline resistance in childhood acute leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403253

Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403253

In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403253

Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403253

Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403253

Detection of the Philadelphia chromosome in interphase nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403253

The role of immunophenotype in acute lymphoblastic leukemia of infant age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403253

Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403253

Resistance of t(4;11) (MLL-AF4 fusion gene) leukemias to stress-induced cell death: possible mechanism for extensive extramedullary accumulation of cells and poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403253

Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403253

Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403253

7 January 2021

Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403253

7 January 2021

Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403253

7 January 2021

Infants with acute lymphoblastic leukemia: no evidence for high methotrexate resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403253

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403253

1 reference

5 December 2017

1 reference